SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 65 filers reported holding SILVERBACK THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 2.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,037,127 | -30.6% | 803,341 | +22.9% | 0.00% | -100.0% |
| Q2 2023 | $4,379,086 | +66.7% | 653,595 | +61.9% | 0.00% | – |
| Q1 2023 | $2,627,462 | +92644.9% | 403,604 | +21.5% | 0.00% | – |
| Q4 2022 | $2,833 | -99.8% | 332,196 | +48.0% | 0.00% | – |
| Q3 2022 | $1,184,000 | +24.9% | 224,384 | +0.3% | 0.00% | – |
| Q2 2022 | $948,000 | -25.5% | 223,652 | -38.3% | 0.00% | – |
| Q1 2022 | $1,272,000 | -51.3% | 362,640 | -7.5% | 0.00% | – |
| Q4 2021 | $2,611,000 | +41.4% | 392,112 | +111.8% | 0.00% | – |
| Q3 2021 | $1,847,000 | -72.9% | 185,112 | -16.1% | 0.00% | -100.0% |
| Q2 2021 | $6,817,000 | -28.5% | 220,688 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $9,538,000 | +970.5% | 218,621 | +1036.9% | 0.00% | – |
| Q4 2020 | $891,000 | – | 19,230 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,618,036 | $80,871,000 | 3.02% |
| Orbimed Advisors | 8,740,887 | $270,006,000 | 2.73% |
| Boxer Capital, LLC | 1,675,377 | $51,752,000 | 1.83% |
| Endurant Capital Management LP | 139,124 | $4,298,000 | 1.18% |
| Nantahala Capital Management | 1,266,266 | $39,115,000 | 1.11% |
| COMMODORE CAPITAL LP | 97,143 | $3,001,000 | 1.05% |
| Ally Bridge Group (NY) LLC | 128,572 | $3,972,000 | 0.99% |
| RA Capital Management | 1,742,186 | $53,816,000 | 0.86% |
| HighVista Strategies LLC | 25,906 | $800,000 | 0.57% |
| SPHERA FUNDS MANAGEMENT LTD. | 173,891 | $5,371,000 | 0.36% |